Stratification of clear cell renal cell carcinoma by signaling pathway analysis

被引:7
|
作者
Cremona, Mattia [1 ]
Espina, Virginia [2 ]
Caccia, Dario [1 ]
Veneroni, Silvia [1 ]
Colecchia, Maurizio [3 ]
Pierobon, Mariaelena [2 ]
Deng, Jianghong [2 ]
Mueller, Claudius [2 ]
Procopio, Giuseppe [4 ]
Lanzi, Cinzia [1 ]
Daidone, Maria Grazia [1 ]
Cho, William C. S. [5 ]
Petricoin, Emanuel F. [2 ]
Liotta, Lance [2 ]
Bongarzone, Italia [1 ]
机构
[1] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy
[2] George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA USA
[3] Fdn IRCCS Ist Nazl Tumori, Dept Pathol, Milan, Italy
[4] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy
[5] Queen Elizabeth Hosp, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China
关键词
autophagy; HIF; hypoxia; mTOR; renal cell carcinoma; reverse-phase protein array; signaling pathway; GROWTH-FACTOR RECEPTOR; TARGETED THERAPY; CANCER; AUTOPHAGY; MTOR; EGFR; VHL; PHOSPHORYLATION; MICRODISSECTION; INACTIVATION;
D O I
10.1586/14789450.2014.893193
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Investigation of cell signaling pathways in 16 clear cell renal cell carcinomas to identify groups based on commonly shared phosphorylation-driven signaling networks. Using laser capture microdissection and reverse-phase protein arrays, we profiled 75 key nodes spanning signaling pathways important in tumorigenesis. Analysis revealed significantly different (P < 0.05) signaling levels for 27 nodes between two groups of samples, designated A (4 samples; high EGFR, RET, and RASGFR1 levels, converging to activate AKT/mTOR) and B (12 samples; high ERK1/2 and STAT phosphorylation). Group B was further partitioned into groups C (7 samples; elevated expression of LC3B) and D (5 samples; activation of Src and STAT). Network analysis indicated that group A was characterized by signaling pathways related to cell cycle and proliferation, and group B by pathways related to cell death and survival. Homogeneous clear cell renal cell carcinomas could be stratified into at least two major functional groups.
引用
收藏
页码:237 / 249
页数:13
相关论文
共 50 条
  • [21] CENPA promotes clear cell renal cell carcinoma progression and metastasis via Wnt/β-catenin signaling pathway
    Qi Wang
    Jiaju Xu
    Zhiyong Xiong
    Tianbo Xu
    Jingchong Liu
    Yuenan Liu
    Jiaping Chen
    Jian Shi
    Yi Shou
    Changjie Yue
    Di Liu
    Huageng Liang
    Hongmei Yang
    Xiong Yang
    Xiaoping Zhang
    Journal of Translational Medicine, 19
  • [22] The PI3K/AKT Pathway and Renal Cell Carcinoma
    Guo, Huifang
    German, Peter
    Bai, Shanshan
    Barnes, Sean
    Guo, Wei
    Qi, Xiangjie
    Lou, Hongxiang
    Liang, Jiyong
    Jonasch, Eric
    Mills, Gordon B.
    Ding, Zhiyong
    JOURNAL OF GENETICS AND GENOMICS, 2015, 42 (07) : 343 - 353
  • [23] Signaling pathways in renal cell carcinoma
    Banumathy, Gowrishankar
    Cairns, Paul
    CANCER BIOLOGY & THERAPY, 2010, 10 (07) : 658 - 664
  • [24] Genomics of Clear-cell Renal Cell Carcinoma: A Systematic Review and Meta-analysis
    Thi Oanh Bui
    Van Tu Dao
    Van Tai Nguyen
    Feugeas, Jean-Paul
    Pamoukdjian, Frederic
    Bousquet, Guilhem
    EUROPEAN UROLOGY, 2022, 81 (04) : 349 - 361
  • [25] Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma
    Lucarelli, Giuseppe
    Rutigliano, Monica
    Ferro, Matteo
    Giglio, Andrea
    Intini, Angelica
    Triggiano, Francesco
    Palazzo, Silvano
    Gigante, Margherita
    Castellano, Giuseppe
    Ranieri, Elena
    Buonerba, Carlo
    Terracciano, Daniela
    Sanguedolce, Francesca
    Napoli, Anna
    Maiorano, Eugenio
    Morelli, Franco
    Ditonno, Pasquale
    Battaglia, Michele
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (07) : 461.e15 - 461.e27
  • [26] Research progress of the Hippo signaling pathway in renal cell carcinoma
    Yang, Yiren
    Gan, Xinxin
    Zhang, Wei
    Zhu, Baohua
    Huangfu, Zhao
    Shi, Xiaolei
    Wang, Linhui
    ASIAN JOURNAL OF UROLOGY, 2024, 11 (04) : 511 - 520
  • [27] Clear Cell Renal Carcinoma: MicroRNAs With Efficacy in Preclinical In Vivo Models
    Weidle, Ulrich H.
    Nopora, Adam
    CANCER GENOMICS & PROTEOMICS, 2021, 18 (03) : 349 - 368
  • [28] Metabolic reprogramming of clear cell renal cell carcinoma
    Zhu, Haiyan
    Wang, Xin
    Lu, Shihao
    Ou, Kongbo
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [29] Targeting apoptosis in clear cell renal cell carcinoma
    Kowalewski, Adam
    Borowczak, Jedrzej
    Maniewski, Mateusz
    Gostomczyk, Karol
    Grzanka, Dariusz
    Szylberg, Lukasz
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 175
  • [30] Validation of Mammalian Target of Rapamycin Biomarker Panel in Patients with Clear Cell Renal Cell Carcinoma
    Haddad, Ahmed Q.
    Kapur, Payal
    Singla, Nirmish
    Raman, Jay D.
    Then, Matthew T.
    Nuhn, Philipp
    Buchner, Alexander
    Bastian, Patrick
    Seitz, Christian
    Shariat, Shahrokh F.
    Bensalah, Karim
    Rioux-Leclercq, Nathalie
    Sagalowsky, Arthur
    Lotan, Yair
    Margulis, Vitaly
    CANCER, 2015, 121 (01) : 43 - 50